Cancer

Sequana Medical announces Extraordinary General Meeting of Shareholders on 10 November 2023

PRESS RELEASEREGULATED INFORMATION06 October 2023, 07:00 am CEST   Ghent, Belgium – 06 October 2023 – Sequana Medical NV (Euronext…

6 months ago

Landmark studies utilizing Olink® Explore technology signal a new era for population-scale proteogenomics

UPPSALA, Sweden, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today reported the publication of three…

6 months ago

Kineta, Inc. Announces Closing of $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

SEATTLE, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA) (the “Company” or “Kineta”), a clinical-stage biotechnology company focused…

6 months ago

Tenth Patient With Depression Starts Dosing MB22001 in Take Home Microdosing Trials

VANCOUVER, BC / ACCESSWIRE / October 5, 2023 / MindBio Therapeutics Corp. (CSE:MBIO);(Frankfurt:WF6), (the "Company" or "MindBio"), is pleased to…

6 months ago

New York-Based FQHC Reports 20% Improvement in Patients Controlling High Blood Pressure and a 17% Increase in Depression Screening Utilizing eClinicalWorks

Betances Health Center establishes standardization and combats physician burnout with eClinicalWorks EHRWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest ambulatory cloud EHR, today…

6 months ago

COSMOS HEALTH CEO Issues Letter to Shareholders

Company reaches major strategic inflection point, with operations and revenue ramp-up underway, to significantly accelerate in 2024 and beyondMaintains solid…

6 months ago

Theralase(R) Files US Patent for Enhanced Immunotherapy

Theralase®'s Latest Preclinical Data Supports Combining Immunotherapy Drugs with Theralase® PDCs for Increased Cancer DestructionTORONTO, ON / ACCESSWIRE / October…

6 months ago

H1 Boosts Flagship Clinical Trial Intelligence Platform with Generative AI to Accelerate Clinical Trials

Seamlessly nestled within Trial Landscape, GenosAI™ enables pharma to look across vast data sets, simplify complex queries, and accelerate clinical…

6 months ago

Fortress Biotech to Present at ROTH MKM 2023 Healthcare Opportunities Conference

MIAMI, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently…

6 months ago